Reporting scoping reviews - PRISMA ScR extension.

[1]  V. Montori,et al.  Endorsement of reporting guidelines and study registration by endocrine and internal medicine journals: meta-epidemiological study , 2019, BMJ Open.

[2]  C. Hiller,et al.  Scoping review of priority setting of research topics for musculoskeletal conditions , 2018, BMJ Open.

[3]  J. McGowan,et al.  PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation , 2018, Annals of Internal Medicine.

[4]  M. Hoxha.  A systematic review on the role of eicosanoid pathways in rheumatoid arthritis. , 2018, Advances in medical sciences.

[5]  David Moher,et al.  Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement , 2018, JAMA.

[6]  Meera Viswanathan,et al.  AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement and checklist. , 2017, Journal of clinical epidemiology.

[7]  Jessica M. Beroes,et al.  An evidence map of the effect of Tai Chi on health outcomes , 2016, Systematic Reviews.

[8]  Melissa C Brouwers,et al.  The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines , 2016, British Medical Journal.

[9]  Susanne Hempel,et al.  What is an evidence map? A systematic review of published evidence maps and their definitions, methods, and products , 2016, Systematic Reviews.

[10]  Sharon E. Straus,et al.  A scoping review on the conduct and reporting of scoping reviews , 2016, BMC Medical Research Methodology.

[11]  David Moher,et al.  PRISMA harms checklist: improving harms reporting in systematic reviews , 2016, British Medical Journal.

[12]  P. Tugwell,et al.  Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration , 2015, International Journal for Equity in Health.

[13]  F. Davidoff,et al.  SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process , 2015, BMJ Quality & Safety.

[14]  Kristian Thorlund,et al.  The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations , 2015, Annals of Internal Medicine.

[15]  Richard D Riley,et al.  Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data: The PRISMA-IPD Statement , 2015 .

[16]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.

[17]  D. Altman,et al.  Using Reporting Guidelines Effectively to Ensure Good Reporting of Health Research , 2014 .

[18]  T. Hoffmann,et al.  Reporting of interventions in randomised trials: an audit of journal Instructions to Authors , 2014, Trials.

[19]  Sally Hopewell,et al.  PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts , 2013, PLoS medicine.

[20]  David Moher,et al.  PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity , 2012, PLoS medicine.

[21]  D. Moher,et al.  Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network , 2010, BMC medicine.

[22]  F. Song,et al.  Dissemination and publication of research findings: an updated review of related biases. , 2010, Health technology assessment.

[23]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[24]  Carl Heneghan,et al.  What is missing from descriptions of treatment in trials and reviews? , 2008, BMJ : British Medical Journal.

[25]  Iveta Simera,et al.  EQUATOR: reporting guidelines for health research , 2008, Open medicine : a peer-reviewed, independent, open-access journal.